US · Technology · Information Technology Services
EPS came in at 0.17 against a street estimate of 0.14 — a beat of 21.4%.
Analysts rate CLARIVATE PLC a hold (2 buy, 5 hold, 1 sell out of 8) with an average price target of $2.97.
| Fund | Stake |
|---|---|
| LEONARD GREEN PARTNERS LP | 18.24% |
| EXOR NV | 10.52% |
| Clarkston Capital Partners, LLC | 7.15% |
| BlackRock Inc | 4.87% |
| Partners Group Holding AG Junk | 4.00% |
| Fidelity International Ltd | 3.95% |
| Dimensional Fund Advisors, Inc. | 2.98% |
| Edmond de Rothschild Holding S.A. | 2.54% |
| Document | Date |
|---|---|
| Acquisition completed · Q4 2026 HEADLINE NUMBERS • Clarivate completed the sale of its Life Sciences and Healthcare business to an affiliate of Altaris, LLC on October 6, 2026. • C | 2026-10-06 |
| Company announcement · Q3 2026 CLARIVATE PLC - FORM 8-K SUMMARY HEADLINE NUMBERS • No specific financial metrics provided in this filing; document is a current report announcement | 2026-09-24 |
| Company announcement · Q3 2026 CLARIVATE PLC - FORM 8-K SUMMARY HEADLINE NUMBERS • Filing Date: September 23, 2026 • Company: Clarivate PLC (ticker: CLVT, NYSE-listed) • Headquart | 2026-09-23 |
| Company announcement · Q3 2026 CLARIVATE PLC - FORM 8-K SUMMARY HEADLINE NUMBERS • Company announced a cash tender offer for certain debt securities on September 17, 2026 • Offer | 2026-09-17 |
| Quarterly report · Q2 2026 CLARIVATE PLC – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenues Q2 2026: $587.3 million (down from $621.4 million in Q2 2025, -5.5%) • Revenues H1 | 2026-07-29 |
| Board / officer change · Q3 2026 CLARIVATE PLC - FORM 8-K SUMMARY July 29, 2026 --- BUSINESS & SEGMENT HIGHLIGHTS • Jonathan Collins resigned as Executive Vice President & Chief Fi | 2026-07-29 |
| Results announced · Q3 2026 CLARIVATE PLC - Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Total Revenues: $587.3 million vs. $621.4 million in Q2 2025 (down 5.5%) • Organ | 2026-07-29 |
| Material agreement · Q3 2026 CLARIVATE PLC – FORM 8-K SUMMARY HEADLINE NUMBERS • Transaction Value: $600,000,000 total purchase price for Life Sciences and Healthcare business • | 2026-07-06 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CLARIVATE PLC — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.